熱門資訊> 正文
Burning Rock Biotech GAAP每股收益为-0.14美元,收入为1,870万美元
2024-08-23 19:39
- Burning Rock Biotech press release (NASDAQ:BNR): Q2 GAAP EPS of -$0.14.
- Revenue of $18.7M (-7.3% Y/Y).
- Cash, cash equivalents, restricted cash and short-term investments were $73.3 million as of June 30, 2024.
More on Burning Rock Biotech
- Burning Rock Biotech joins hands with Bayer to expand precision cancer therapies portfolio
- Financial information for Burning Rock Biotech
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。